INTERFERONS IN THE THERAPY OF SOLID TUMORS

被引:32
作者
AGARWALA, SS [1 ]
KIRKWOOD, JM [1 ]
机构
[1] UNIV PITTSBURGH, MED CTR, PITTSBURGH CANC INST, DIV MED ONCOL, PITTSBURGH, PA 15213 USA
关键词
INTERFERONS; THERAPY; TUMORS; MELANOMA; REVIEW; SYSTEMIC; IMMUNOTHERAPY; CHEMOTHERAPY;
D O I
10.1159/000227327
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interferons, a group of naturally occurring proteins, possess potent immunological effects. The availability of large amounts of purified interferon through recombinant DNA technology has led to the testing of these agents against a number of tumor types. Interferon-alpha has been the most widely studied. The most encouraging results have been observed in the treatment of melanoma among nonhematological neoplasms, and in the locoregional treatment of other tumor types. It is hoped that further research into the use of the interferons, both singly and in combination with chemotherapy and other immunological agents, will lead to a better elucidation of their therapeutic role against cancer. In this article, the use of interferons in the treatment of solid tumors is reviewed.
引用
收藏
页码:129 / 136
页数:8
相关论文
共 91 条
  • [1] AAPRO MS, 1983, CANCER CHEMOTH PHARM, V10, P161
  • [2] COMBINATION CHEMOTHERAPY AND INTERFERON ALPHA-2B IN THE TREATMENT OF ADVANCED NON SMALL-CELL LUNG-CANCER
    ARDIZZONI, A
    ROSSO, R
    SALVATI, F
    SCAGLIOTTI, G
    SORESI, E
    FERRARA, G
    PENNUCCI, C
    BALDINI, E
    CRUCIANI, AR
    ANTILLI, A
    TONACHELLA, R
    RINALDI, M
    GENOVESE, G
    CRIPPA, M
    GATTI, E
    FORTINI, C
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (02): : 120 - 123
  • [3] HOME THERAPY WITH RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN ADVANCED HUMAN MALIGNANCIES
    ATZPODIEN, J
    KORFER, A
    FRANKS, CR
    POLIWODA, H
    KIRCHNER, H
    [J]. LANCET, 1990, 335 (8704) : 1509 - 1512
  • [4] BELLDEGRUN A, 1990, EUR UROL, V18, P42
  • [5] BEREK JS, 1985, CANCER RES, V45, P4447
  • [6] BEZWODA WR, 1989, CANCER, V64, P1029, DOI 10.1002/1097-0142(19890901)64:5<1029::AID-CNCR2820640511>3.0.CO
  • [7] 2-#
  • [8] TREATMENT OF MALIGNANT ASCITES DUE TO RECURRENT REFRACTORY OVARIAN-CANCER - THE USE OF INTERFERON-ALPHA OR INTERFERON-ALPHA PLUS CHEMOTHERAPY INVIVO AND INVITRO
    BEZWODA, WR
    GOLOMBICK, T
    DANSEY, R
    KEEPING, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (11) : 1423 - 1429
  • [9] CANCER STATISTICS, 1993
    BORING, CC
    SQUIRES, TS
    TONG, T
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1993, 43 (01) : 7 - 26
  • [10] ADJUVANT THERAPY WITH ESCALATING DOSES OF DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH OR WITHOUT LEUKOCYTE ALPHA-INTERFERON FOR STAGE-II OR STAGE-III BREAST-CANCER
    BUZDAR, AU
    HORTOBAGYI, GN
    KAU, SWC
    SMITH, TL
    FRASCHINI, G
    HOLMES, FA
    GUTTERMAN, JU
    HUG, VM
    SINGLETARY, SE
    AMES, FC
    MCNEESE, MD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) : 1540 - 1546